Drug treatment of inflammatory bowel disease.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000930:Antidiarrheals / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000276:immunology; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology; D004205:Cromolyn Sodium / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007109:Immunity; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D008795:Metronidazole / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D012460:Sulfasalazine / Q000627:therapeutic use; D014165:Transfer Factor / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000930:Antidiarrheals; D001500:BCG Vaccine; D007166:Immunosuppressive Agents; D014165:Transfer Factor; D008795:Metronidazole; D007978:Levamisole; D012460:Sulfasalazine; D000324:Adrenocorticotropic Hormone; D001379:Azathioprine; D004205:Cromolyn Sodium